MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


TOP NEWS: Mediclinic accepts sweetened £3.7 billion takeover offer

ALN

Mediclinic International PLC announced on Thursday it had accepted a sweetened offer from a consortium led by the Johannesburg-listed investment firm Remgro Ltd.

SAS Shipping Agencies Services Sarl is a consortium comprising Remgro and MSC Mediterranean Shipping Co SA. Remgro holds a 45% stake in Mediclinic.

The consortium revised its offer to 504 pence in cash for each Mediclinic share held, up 9.5% from 460p offered in May. Mediclinic rebuffed this initial takeover bid.

Shares in Mediclinic were 2.0% stronger at 499.60 pence each in London on Thursday morning. The shares were 2.7% higher in Johannesburg at R 101.36.

The proposed acquisition values Mediclinic at about £3.7 billion, representing a premium of around 50% to the volume-weighted average price per Mediclinic share of 337p for six months to May 25. On an enterprise value basis, including debt, it values it at £6.1 billion.

The proposed deal is subject to shareholder and regulatory approvals.

Mediclinic, which received advice from Morgan Stanley and UBS, considered the fresh offer as ‘fair and reasonable’.

The Stellenbosch-based private hospitals operator intends to recommend unanimously this new proposal at the general meeting.

Mediclinic Chair Dame Inga Beale said the recommended offer represented a near-term value realisation for Mediclinic shareholders at an attractive premium.

‘Together with SAS, the consortium's resources will put Mediclinic in a strong position to continue to serve patients through our broad range of high-quality healthcare services,’ Beale said.

Commenting on the deal, Remgro Chief Executive Jannie Durand said that under the stewardship of the consortium, Mediclinic will be well-positioned to execute on its strategy and undertake the investment required to realise the full potential of the business.

MSC President Diego Aponte said: ‘We believe that, alongside Remgro, our ownership will provide Mediclinic with significant resources to the benefit of all of Mediclinic's stakeholders, including in particular its patients, employees, doctors and host governments.’

Remgro stock rose by 0.6% to R 138.30 in Johannesburg.

Copyright 2022 Alliance News Limited. All Rights Reserved.